ECR 2013 – Final Programme - myESR.org

Scientific Sessions11:51B-0020 Relationship among fractional anisotropy (FA) values,EEG activity and cognitive status in mild cognitiveimpairment (MCI) and Alzheimer’s disease (AD)patientsF. Pitocco, G. Curcio, F. Scrascia, Y. Errante, A. Giona, C. Mallio, F. Vernieri,B. Beomonte Zobel, C. Quattrocchi; Rome/IT10:30–12:00 Room D1ChestSS 104Lung cancer: from tissuecharacterisation to treatmentModerators: E. Castañer; Sabadell/ES, N. Tacelli; Brussels/BE10:30B-0021 Prognostic value of CT perfusion parameters inpatients with early stage resectable non-small celllung cancerL. Calandriello, A.R. Larici, A. del Ciello, G. Rindi, G. Petrone, L. Bonomo; Rome/IT10:39B-0022 Dynamic volume perfusion CT in patients with lungcancer: baseline perfusion characteristics of differenthistological subtypesJ. Shi 1 , C. Fink 2 , G. Schmid-Bindert 3 , L.R. Pilz 3 , P. Apfaltrer 3 , H. Haubenreisser 3 ,U. Haberland 4 , S.O. Schönberg 3 , T. Henzler 3 ; 1 Shanghai/CN, 2 Celle/DE,3Mannheim/DE, 4 Forchheim/DE10:48B-0023 Correlation between grade and histologicalsubtype of pulmonary adenocarcinoma and [18F]fluorodeoxyglucose standardized uptake value afterevaluation by PET/CTL. Xu, A. Burke, S. Feigenberg; Baltimore, MD/US10:57B-0024 Which response criteria best help predict survivalof patients with EGFR-mutant lung adenocarcinomafollowing EGFR tyrosine kinase inhibitor?J. Lee, H. Lee, J.-H. Kim, M.-J. Ahn, H. Kang, K. Lee; Seoul/KR11:06B-0025 Radiogenomic approach to identify anaplasticlymphoma kinase-positive lung adenocarcinomaC. Jeong, H. Lee, J. Han, J. Jeong, K. Lee, K. Park, M.-J. Ahn, B.-T. Kim; Seoul/KR11:15B-0026 Mucinous vs nonmucinous adenocarcinoma in situ(AIS): imaging features, EGFR mutation and EGFR genecopy number status, and prognosisD. Kim, H.-J. Lee, J. Wi, S. Lee, C. Park, J. Goo; Seoul/KR11:24B-0027 Validation of a computed-tomography-based riskmodel for the prediction of cardiovascular disease in alung cancer screening settingP.M. Jairam, P.A. de Jong, W.P.T.M. Mali, Y. van der Graaf; Utrecht/NL11:33B-0028 Diagnostic accuracy of virtual 18F-FDG PET/CTbronchoscopy for the detection of lymph nodemetastases in non-small cell lung cancer patientsM.C. Herbrik 1 , C. Buchbender 2 , J. Treffert 3 , B. Geiger 4 , V. Hartung-Knemeyer 1 ,H. Kühl 1 , G. Antoch 2 , M. Forsting 1 , T.A. Heusner 2 ; 1 Essen/DE, 2 Düsseldorf/DE,3Knoxville, TN/US, 4 Princeton, NJ/US11:42B-0029 Percutaneous transthoracic CT-guided biopsy usinglarge core needles: initial experienceU.C. Lalji, J.E. Wildberger, M. Bendek, M. Das; Maastricht/NL11:51B-0030 Primary lung cancer treated using radiofrequencyablation: two-year outcome dataJ. Beeson, N. Wickings, V. Anikin, S. Kaul, P. Dalal; London/UK10:30–12:00 Room D2Interventional RadiologySS 109 Chemoembolisation andradioembolisation of liver tumoursModerators: A. Denys; Lausanne/CH, P.M. Paprottka; Munich/DE10:30B-0031 Repeated transarterial chemoembolization in thetreatment of liver metastases of colorectal cancer:local tumour control and survival dataT. Gruber-Rouh, N.N.N. Naguib, M. Beeres, B. Bodelle, S. Zangos, N. Nour Eldin,R. Hammerstingl, T.J. Vogl; Frankfurt/DE10:39B-0032 Holmium-166 radioembolisation: results of a phase 1,dose escalation study in patients with unresectable,chemorefractory liver metastases – the HEPAR trialM.L.J. Smits, J.F.W. Nijsen, M.A.A.J. van den Bosch, M.G.E.H. Lam, M.A.D. Vente,W.P.T.M. Mali, A.D. van het Schip, B.A. Zonnenberg, J.F. Prince; Utrecht/NL10:48B-0033 Repetitive transarterial chemoembolization as apalliative treatment option for liver metastasesfrom cutaneous malignant melanoma: indications,outcomes and role in patient’s managementT. Gruber-Rouh, P. Weisser, N.N.N. Naguib, K. Eichler, M. Harth, S. Zangos, N.-E.A. Nour-Eldin, T.J. Vogl; Frankfurt/DE10:57B-0034 Experimental study on transarterial administrationof survivin siRNA combined with transarterialchemoembolization in rats with hepatocellularcarcinoma (HCC)T.J. Vogl 1 , J. Qian 2 , A. Tran 1 , E. Oppermann 1 , U. Imlau 1 , Y. Hamidavi 1 ,H. Korkusuz 1 , W.O. Bechstein 1 ; 1 Frankfurt a. Main/DE, 2 Wuhan/CN11:06B-0035 Role of transarterial chemoembolization as bridgingstrategy in T2 HCC patients on the waiting listE. Bozzi, I. Bargellini, F. Turini, A. Cicorelli, R. Cioni, C. Bartolozzi; Pisa/IT11:15B-0036 Semi-automatic volumetric tumour segmentation forhepatocellular carcinoma: comparison between C-armcone-beam computed tomography and MRIV. Tacher 1 , M. Lin 2 , M. Chao 1 , L. Gjesteby 1 , N. Bhagat 1 ; 1 Baltimore, MD/US,2Briarcliff Manor, NY/US11:24B-0037 Transcatheter arterial chemoembolisation ofhepatocellular carcinoma in transplant patients:smaller bead diameter and hypervascularity lead tohigher tumour necrosisM. Hakky, S. Amirifeli, C. Wald, C. Molgaard, H. Ahari; Burlington, MA/US11:33B-0038 Initial RECIST tumour reduction as a predictiveparameter for transarterial chemoembolisationtreatment success in patients with hepatocellularcarcinomaD.B. Hasdemir, B.C. Meyer, N. Schweitzer, A. Vogel, C. von Falck, H. Rosenthal,F. Wacker, T. Rodt; Hannover/DEB-0020 – B-0038Thursday215